Alamar Biosciences opens at $22.60, IPO priced at $17 per share

Alamar Biosciences (ALMR) priced 11.25M shares at $17.00. The deal size was increased and priced at the high-end of the range. Alamar is a life sciences company that says its platform is designed to detect biomarkers with ultra-high sensitivity and “address key limitations of existing technologies, helping researchers unlock the full spectrum of protein biomarkers across disease states.”